JAGSNPHARM Shareholding Pattern: Promoter, FII & DII Holding (JAGSNPHARM)

JAGSNPHARM latest shareholding pattern: promoter holding, FII / FPI holding, DII and mutual fund holding, public holding and number of shareholders, quarter by quarter.

  • JAGSNPHARM Financials
  • JAGSNPHARM Shareholding Pattern
  • JAGSNPHARM Earnings Documents
  • JAGSNPHARM Announcements
  • JAGSNPHARM Corporate Actions
  • JAGSNPHARM Bulk, Block & Insider Deals
  • JAGSNPHARM Delivery Data
  • JAGSNPHARM Earnings Concalls
  • Market Timeline
  • Concall Monitor
  • Company Research
  • Earnings Monitor
  • Upcoming Results
  • Sector Monitor
  • Sector Performance
  • Bulk & Block Deals
  • Delivery Data
  • FII & DII Activity
  • Market Indices
  • Plans & Pricing

Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM) Shareholding Pattern - Promoter, FII, DII & Public Holdings

As of Sep 2026, promoters held 68.82% of Jagsonpal Pharmaceuticals Ltd, FIIs 2.13%, DIIs 1.64%, government - and the public 27.4%, across 26,537 shareholders.

JAGSNPHARM shareholding pattern, quarterly (%)
MetricDec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Promoters67.82%67.77%67.65%67.54%67.39%67.89%69.06%68.82%
FIIs2.1%2.1%2.17%2.12%2.12%2.44%2.3%2.13%
DIIs0%0%0.05%0.08%0.15%0.22%0.62%1.64%
Public30.1%30.11%30.12%30.25%30.34%29.44%28.04%27.4%
No. of Shareholders18,47121,08522,89924,65324,89526,26424,18126,537
JAGSNPHARM shareholding pattern, yearly (%)
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Promoters68.71%68.72%68.09%67.77%67.89%68.82%
FIIs0%0.1%0.73%2.1%2.44%2.13%
DIIs0.67%0.82%0.84%0%0.22%1.64%
Public30.61%30.34%30.33%30.11%29.44%27.4%
No. of Shareholders17,10014,08416,28221,08526,26426,537
  • JAGSNPHARM Financials
  • JAGSNPHARM Earnings Concalls
  • JAGSNPHARM Growth Catalysts
  • JAGSNPHARM Corporate Actions
  • JAGSNPHARM Announcements
  • JAGSNPHARM Results & Documents
  • JAGSNPHARM Bulk & Block Deals
  • JAGSNPHARM Delivery Data